Labiotech.eu

News and Trends 3 Sep 2018

Oxford Biotech Raises €40M to Deliver Drugs to Hard-to-Reach Targets

Evox Therapeutics has raised £35.5M (€39.4M) in a Series B fundraising that has been backed, among others, by the venture arm of Google’s parent company. A spin-out from the University of Oxford and the Karolinska Institute, Evox Therapeutics has raised a large round that will fund the development of its drug delivery technology to […]

September 3, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Interview 3 Sep 2018

Moving from Big Pharma to Biotech – Insights from Two Biotech CEOs

According to John LaMattina in Forbes last year, more and more senior scientific executives are moving from pharma to small biotechs or startup initiatives. While the jury is out on whether this observation reflects a real trend or not, we at Labiotech are keen to learn about what drives people to make such a move! […]

September 3, 2018 - 11 minutesmins - By External Contributor

victoria shennan anthropocene microbial music

News and Trends 1 Sep 2018

A Symphony Inspired by the Microbes Living on Us

British artist Victoria Shennan has created a musical composition based on the microorganisms that form an essential part of us. We are just starting to realize the huge role that microorganisms play in our well-being and the proper functioning of our bodies. Research on the human microbiome in the last decade has linked the […]

September 1, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Genomics partner Vertex big genomic data

News and Trends 31 Aug 2018

Vertex Partners Oxford Genome Analysis Firm To Develop New Personalized Therapies

Genomics, a company using machine learning to analyze genetic data, is partnering with precision medicine specialists Vertex Pharmaceuticals to develop new therapies in a 3-year collaboration. The agreement marks the closing of the Oxford-based company’s €28M (£25M) series B fundraising round, as Vertex has also invested €11.7M (£10.5M) in Genomics. If the collaboration is successful […]

August 31, 2018 - 2 minutesmins - By Helen Albert

News and Trends 30 Aug 2018

First RNAi Drug Approved in Europe After 20 Years of Research

The first ever RNA interference (RNAi) drug, used to treat polyneuropathy in patients with hereditary transthyretin-mediated amyloidosis, has been given marketing approval by the European Commision. The approval follows that of the US FDA who gave the green light to US biotech Alnylam Pharmaceutical’s Onpattro (patisiran) earlier this month following positive Phase III findings in […]

August 30, 2018 - 3 minutesmins - By Helen Albert

Expert Advice 30 Aug 2018

7 Ingredients a Life Science Infographic Needs to Go Viral

Infographics enjoyed a hay day in the early 2010s. They were a fresh idea and a welcome change to the standard blog post format which the internet was already flooded with. They worked so well in catching the consumers’ attention, that their decline came as quickly as their rise. As with any new medium, […]

August 30, 2018 - 9 minutesmins - By James Mathison

News and Trends 29 Aug 2018

Women’s Health Biotech Raises €28M to Fund Phase II Menopause Drug Trial

UK-biotech KaNDy Therapeutics closed a £25M (€28M) series C round to help finance the upcoming Phase IIb trial of its lead candidate for treating symptoms of the menopause. Unlike other therapies aimed at treating the same symptoms, KaNDy’s drug (NT-814) is not based on hormone replacement therapy, which can take a long time to be […]

August 29, 2018 - 2 minutesmins - By Helen Albert

News and Trends 29 Aug 2018

Affimed Collaborates with Genentech in Cancer Immunotherapy Deal Worth €4.4B

The German biotech will partner with Genentech, part of the Roche Group, to develop targeted cancer therapies that engage both innate and adaptive immune cells. Affimed will receive €82M ($96M) upfront from the US giant to develop its immunotherapy ROCK (Redirected Optimized Cell Killing) platform, which uses both natural killer cells and T-cells to target […]

August 29, 2018 - 2 minutesmins - By Helen Albert

In Depth 29 Aug 2018

How Big is the Investment Gap Between Biotech and Digital? (Smaller Than You Think…)

Many people outside of biotech may wonder how the size of the biotech industry compares to the digital industry, and even biotech experts often don’t know the answer. Here we’ll take a look at how the two industries compare and how they are expected to develop in the future. We cannot get around the fact […]

August 29, 2018 - 7 minutesmins - By Editorial Team

News and Trends 28 Aug 2018

Update: Gilead and Novartis’s CAR T-Cell Therapies Approved in Europe

Update: Following on from earlier approvals in the US, the European Commission announced it has given marketing approval for both Gilead’s Yescarta and Novartis’s Kymriah for treatment of patients with various forms of blood cancer. Yescarta (axicabtagene ciloleucel) can be used to treat adults with a relapsed or refractory form of the blood cancer diffuse large […]

August 28, 2018 - 4 minutesmins - By Editorial Team

News and Trends 25 Aug 2018

Are Fungi the Answer to a More Sustainable Future?

The exhibition Fungal Futures, in Belgium, showcases multiple objects that are made using fungi, offering a peek into a future of sustainable materials. We are in dire need of sustainable materials that provide an environmentally-friendly alternative to plastic and other materials that cause pollution and end up crowding landfills. The solution could be fungi. These […]

August 25, 2018 - 5 minutesmins - By Clara Rodríguez Fernández

More News! 24 Aug 2018

Shire gets US market approval for rare inflammatory disease drug

The UK-US biotech giant’s drug Takhzyro has been approved by the FDA to prevent attacks of hereditary angioedema, a rare genetic disease that causes swelling around the body. Hereditary angioedema is a potentially life threatening genetic condition that people can inherit from either of their parents. Takhzyro (lanadelumab-flyo) is a first-in-class monoclonal antibody drug that […]

August 24, 2018 - 2 minutesmins - By Helen Albert

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Oxford Biotech Raises €40M to Deliver Drugs to Hard-to-Reach Targets

Moving from Big Pharma to Biotech – Insights from Two Biotech CEOs

A Symphony Inspired by the Microbes Living on Us

Vertex Partners Oxford Genome Analysis Firm To Develop New Personalized Therapies

First RNAi Drug Approved in Europe After 20 Years of Research

7 Ingredients a Life Science Infographic Needs to Go Viral

Women’s Health Biotech Raises €28M to Fund Phase II Menopause Drug Trial

Affimed Collaborates with Genentech in Cancer Immunotherapy Deal Worth €4.4B

How Big is the Investment Gap Between Biotech and Digital? (Smaller Than You Think…)

Update: Gilead and Novartis’s CAR T-Cell Therapies Approved in Europe

Are Fungi the Answer to a More Sustainable Future?

Shire gets US market approval for rare inflammatory disease drug

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!